GenoMethods - Biotechnology, Bioinformatics & AI in Biology

HLB gets FDA green light for Refiktu in bile duct cancer

HLB’s US arm Elevar Therapeutics has landed FDA approval for Refiktu, an oral drug for FGFR2-altered cholangiocarcinoma. This first for South Korean pharma opens the door to global expansion.

By Elena MacLeod · September 28, 2026, 11:14 AM · 3 mins read

Clinical Trials & Evidence

Gene edited stem cell transplants shield healthy blood from targeted leukemia therapy

By Elena MacLeod

Drug Discovery

Precision therapies reshape the fight against glioblastoma multiforme

By Elena MacLeod

Drug Discovery

Pancreatic cancer survival rises as new therapies break through clinical barriers

By Elena MacLeod

Clinical Trials & Evidence

Cancer clinical trials hit access roadblocks as Sylvester Center pushes for change

By Elena MacLeod

IN-DEPTH REPORTING

Genome Editing

Colossal Biosciences delays woolly mammoth comeback to 2030s

Colossal Biosciences has pushed its woolly mammoth de-extinction goal into the early 2030s after running into tougher genetic problems than expected.

By Adrian Cole · September 28, 2026, 8:21 AM

CAR-T & Engineered Cell Therapy

Ligand backs AvenCell with $47 million to push next-gen CAR T therapies

September 26, 2026, 8:25 PM

Clinical Trials & Evidence

FDA clears first clinical trial for solid tumor CAR-T therapy targeting B7-H3 and IL-8

September 26, 2026, 6:11 PM

BIOTECHNOLOGY NEWS & ANALYSIS >

Genomics & Multiomics

Brain atlas growth stalls clinical progress without real-world testing

A new editorial says bigger brain atlases alone won't lead to better treatments unless researchers test function and set clear data standards.

By Adrian Cole · September 25, 2026, 5:44 PM

Biotech Companies & Pipelines

Zymeworks completes Theravance Biopharma buyout, adds new assets and revenue streams

September 25, 2026, 1:33 PM

Biotechnology News & Analysis

Dark genome mutations spark different inflammation routes in aging blood cells

September 25, 2026, 9:27 AM

CLINICAL TRIALS & EVIDENCE >

AI in Biology

Nvidia sets up Israeli AI group to push medical and scientific breakthroughs

Nvidia has launched the Applied AI Architecture group in Israel, looking to drive new progress in medicine and science through AI research and partnerships.

By Adrian Cole · September 24, 2026, 9:08 PM

Drug Discovery

Experimental CAR T cell therapy wipes out metastatic liver cancer in three-year-old

September 24, 2026, 2:59 PM

Drug Discovery

New myasthenia gravis trial results set to reshape neuromuscular medicine at AANEM 2026

September 24, 2026, 9:54 AM

Biotechnology, Decoded

GenoMethods explains biotechnology from method to medicine to market, connecting scientific evidence, clinical development, companies and the technologies shaping future health.

TOP STORIES

HLB gets FDA green light for Refiktu in bile duct cancer

Gene edited stem cell transplants shield healthy blood from targeted leukemia therapy

Precision therapies reshape the fight against glioblastoma multiforme

Pancreatic cancer survival rises as new therapies break through clinical barriers

Cancer clinical trials hit access roadblocks as Sylvester Center pushes for change

IN-DEPTH REPORTING

Colossal Biosciences delays woolly mammoth comeback to 2030s

Ligand backs AvenCell with $47 million to push next-gen CAR T therapies

FDA clears first clinical trial for solid tumor CAR-T therapy targeting B7-H3 and IL-8

FEATURED STORIES

Senator Todd Young demands White House biotech chief as China races ahead

Zymeworks grabs Theravance in $929 million respiratory buyout

Australian manufacturing drives new CAR-T trial for solid tumours

AI agent spots viral DNA repeats that mirror CRISPR

Ulefnersen slows ALS decline in pivotal FUS gene trial

Living drugs upend cancer treatment at Tang Prize Masters Forum

BIOTECHNOLOGY NEWS & ANALYSIS >

Brain atlas growth stalls clinical progress without real-world testing

Zymeworks completes Theravance Biopharma buyout, adds new assets and revenue streams

Dark genome mutations spark different inflammation routes in aging blood cells

CLINICAL TRIALS & EVIDENCE >

Nvidia sets up Israeli AI group to push medical and scientific breakthroughs

Experimental CAR T cell therapy wipes out metastatic liver cancer in three-year-old

New myasthenia gravis trial results set to reshape neuromuscular medicine at AANEM 2026

Biotechnology, Decoded